Two high calibre clinicians have been awarded funding from the charity Yorkshire Cancer Research. The clinical research training fellowships have been awarded to Dr Oliver Donelly and Dr Mark Teo, from Leeds Institute of Molecular Medicine based at St. James's university hospital in Leeds.
Commenting on his work, Dr Oliver Donnelly, who was awarded £192,319, said: "Certain viruses have been shown, in the laboratory, to be able to kill cancer cells. Combining cell and viral therapy for cancer is an exciting new approach to cancer therapy."
Dr Mark Teo, who was awarded £190,337, commented: "My research aims to find new rare genetic variants of two genes involved in DNA repair that might increase the risk of developing bladder cancer. This information may help us in the future to identify people at high risk of bladder cancer who would benefit from intervention to prevent this disease developing."
To find out more information on the work funded by Yorkshire Cancer Research please visit the website www.ycr.org.uk
